B Cell–Directed Therapy in Autoimmunity
I Abeles, C Palma, N Meednu, AS Payne… - Annual Review of …, 2023 - annualreviews.org
Autoimmune diseases with B cell–directed therapeutics approved by the US Food and Drug
Administration are surprisingly diverse in clinical manifestations and pathophysiology. In this …
Administration are surprisingly diverse in clinical manifestations and pathophysiology. In this …
The lung as a target and as an initiator of rheumatoid arthritis-associated immunity: Implications for interstitial lung disease
ML Haarhaus, L Klareskog - Revista Colombiana de Reumatología, 2024 - Elsevier
Interstitial lung disease (ILD) is a serious extra-articular co-morbidity in rheumatoid arthritis
(RA) patients and accounts for a substantial part of the increased mortality in RA. In this …
(RA) patients and accounts for a substantial part of the increased mortality in RA. In this …